How much coffee should you drink for the biggest benefit?
The sweet spot appears to be 2 to 3 cups per day. In a UK Biobank study of nearly 450,000 people, those who drank 2–3 cups of coffee daily had the lowest risk of death from any cause — about 14% lower for decaf, 27% lower for ground coffee, and 11% lower for instant coffee compared to non-drinkers [7]. Another large UK Biobank analysis of over 468,000 participants found that light-to-moderate drinkers (0.5–3 cups/day) had a 12% lower risk of all-cause mortality than non-drinkers [8].
Drinking more than 3 cups per day still shows a benefit, but the effect tends to plateau or even reverse slightly. For example, a study of over 171,000 UK adults found that drinking more than 4.5 cups of unsweetened coffee per day was still linked to a 23% lower risk of death, but the benefit was not as large as at 2.5–3.5 cups per day (29% lower risk) [1]. A study of Korean adults found that those who drank more than 3 cups per day had a 21% lower risk of all-cause mortality compared to non-drinkers [6].
Does the type of coffee or what you add to it matter?
Yes, what you add to your coffee can make or break the health benefit. A large UK Biobank study found that unsweetened coffee drinkers had a 16–29% lower risk of death depending on how much they drank, while sugar-sweetened coffee drinkers saw a smaller and less consistent benefit — only those drinking 1.5–2.5 cups per day had a statistically significant 31% lower risk [1]. Artificially sweetened coffee showed an even weaker and less reliable association [1]. A US study of over 46,000 adults confirmed that the mortality benefit was restricted to black coffee (14% lower risk) and coffee with low added sugar and saturated fat (14% lower risk) [3].
The type of coffee bean also seems to matter less than you might think. Ground, instant, and decaffeinated coffee all showed significant reductions in all-cause mortality in the UK Biobank — ground coffee at 2–3 cups per day had the strongest effect (27% lower risk), but instant and decaf also reduced risk by 11–14% [7]. A Mediterranean study of over 1,500 adults found that caffeinated coffee, but not decaf, was linked to lower all-cause mortality over 18 years of follow-up [10]. So while caffeine may play a role, it is not the whole story.
When you drink coffee and who you are also matter
Drinking coffee in the morning may be more beneficial than drinking it throughout the day. A US study of over 40,000 adults found that morning coffee drinkers had a 16% lower risk of all-cause mortality compared to non-drinkers, while all-day drinkers did not see a significant benefit — even after adjusting for total coffee intake [5]. This suggests that timing may disrupt circadian rhythms or sleep quality when coffee is consumed later in the day.
For people with existing health conditions, the evidence is mixed but largely reassuring. In patients with atrial fibrillation (a common heart rhythm disorder), daily coffee drinkers had a 23% lower risk of major cardiovascular events and lower all-cause mortality compared to non-daily drinkers [9]. Among colorectal cancer survivors, drinking more than 4 cups per day was linked to a 32% lower risk of cancer recurrence and a 32% lower risk of death compared to drinking less than 2 cups [4]. However, a Japanese study found that heavy coffee consumption (2 or more cups per day) was associated with a doubled risk of cardiovascular death in people with severe hypertension (grade 2–3), but not in those with normal or mildly elevated blood pressure [11]. This is an important caveat: if your blood pressure is poorly controlled, heavy coffee intake may not be safe.
About These Sources
This answer is built on 11 peer-reviewed studies — published from 2021 to 2025, 4 from 2024 or later, 9 in Q1 journals, collectively cited 458 times — selected as the most relevant from 15 studies that passed quality screening, drawn from 49 papers retrieved from a database of over 500 million.
Sources used in this answer
Association of Sugar-Sweetened, Artificially Sweetened, and Unsweetened Coffee Consumption With All-Cause and Cause-Specific Mortality
In a UK Biobank cohort of 171,616 adults, moderate consumption of unsweetened and sugar-sweetened coffee was associated with lower all-cause mortality, with the strongest benefit at 2.5–3.5 cups/day (29% lower risk for unsweetened). Artificially sweetened coffee showed a less consistent association.
Consumption of coffee and tea with all-cause and cause-specific mortality: a prospective cohort study
In a UK Biobank study of 498,158 adults, drinking 1 cup of coffee or 3 cups of tea per day was linked to the lowest mortality risk; combining <1–2 cups coffee with 2–4 cups tea gave a 22% lower all-cause mortality risk.
Coffee Consumption and Mortality among United States Adults: A Prospective Cohort Study
In a US NHANES study of 46,222 adults, higher coffee consumption was associated with lower all-cause mortality (16% lower at 1–2 cups/day), but the benefit was restricted to black coffee or coffee with low added sugar and saturated fat.
Coffee consumption is associated with a reduced risk of colorectal cancer recurrence and all‐cause mortality
In a prospective cohort of 1,719 colorectal cancer patients in the Netherlands, drinking >4 cups of coffee per day was associated with a 32% lower risk of recurrence and a 32% lower risk of all-cause mortality compared to <2 cups/day.
Coffee drinking timing and mortality in US adults
In a US NHANES study of 40,725 adults, morning coffee drinkers had a 16% lower risk of all-cause mortality compared to non-drinkers, while all-day drinkers did not show a significant benefit.
Coffee Consumption and the Risk of All-Cause and Cause-Specific Mortality in the Korean Population
In a Korean cohort of 110,920 adults, drinking >3 cups of coffee per day was associated with a 21% lower risk of all-cause mortality; moderate consumption (1–3 cups/day) was linked to a 38% lower risk of cardiovascular mortality.
The impact of coffee subtypes on incident cardiovascular disease, arrhythmias, and mortality: long-term outcomes from the UK Biobank
In a UK Biobank study of 449,563 adults, all coffee subtypes (decaf, ground, instant) were associated with reduced all-cause mortality; the greatest reduction was with 2–3 cups/day of ground coffee (27% lower risk).
Light to moderate coffee consumption is associated with lower risk of death: a UK Biobank study
In a UK Biobank study of 468,629 adults, light-to-moderate coffee consumption (0.5–3 cups/day) was associated with a 12% lower risk of all-cause mortality and a 17% lower risk of cardiovascular mortality.
Coffee consumption and adverse cardiovascular events in patients with atrial fibrillation
In a cohort of atrial fibrillation patients (Swiss-AF and Beat-AF), daily coffee consumption was associated with a 23% lower risk of major cardiovascular events and lower all-cause mortality compared to non-daily consumption.
Coffee Consumption and All-Cause, Cardiovascular, and Cancer Mortality in an Adult Mediterranean Population
In a Mediterranean cohort of 1,567 adults, drinking >1 cup of coffee per day was associated with a 44% lower risk of all-cause mortality over 18 years; the benefit was significant for caffeinated but not decaffeinated coffee.
Coffee and Green Tea Consumption and Cardiovascular Disease Mortality Among People With and Without Hypertension
In the Japan Collaborative Cohort Study (18,609 participants), heavy coffee consumption (≥2 cups/day) was associated with a doubled risk of cardiovascular mortality in people with severe hypertension (grade 2–3), but not in those with normal or mildly elevated blood pressure.